Today, Cadence is announcing our $100M Series C, led by
@SparkCapital, with participation from
@ThriveCapital,
@generalcatalyst,
@coatuemgmt,
@BCapitalGroup, Corewell Health Ventures, Memorial Hermann, and Duke Health.
Together with the leading health systems in the US, we are automating the treatment of chronic disease, delivering better outcomes to 100,000 patients.
Our clinical AI monitors patients daily, surfaces risk early, coordinates action, and extends clinicians so they can focus on the decisions that require them. The results:
- 27% fewer hospital admissions
- $1,302 annual cost reduction per patient
- $2.7M in Medicare savings every week
- 70% relative improvement in blood pressure control
- Median alert response time of 3.5 minutes
AI is improving clinical care. This round is about scaling world-class care from 100,000 patients to millions.
I’m deeply grateful to our patients, partners, investors, and every member of the Cadence team.
We’re building the standard for how chronic disease gets treated in America.
